Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Haloperidol
Placebo
+2 more
Locations
1
Canada
Centre for Addiction and Mental Health
Toronto, Ontario, Canada
Start Date
December 11, 2025
Primary Completion Date
August 1, 2028
Completion Date
December 1, 2028
Last Updated
April 2, 2026
NCT04810858
NCT07477184
NCT02290834
NCT06780917
NCT07284290
NCT07231497
Lead Sponsor
Centre for Addiction and Mental Health
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions